- ホーム
- > 電子洋書
Description
This book summarizes the present knowledge of oxidative stress in anti-cancer drug-induced cardiotoxicity and covers cell molecular mechanisms, prevention and treatment strategies, drug research, and population experiments. Racial and gender disparities in anticancer therapy-related cardiotoxicity are also covered. Book chapters provide current and timely review of hypothesis-driven research, case studies, and review articles. As such, this book serves as a source of knowledge and guidance for research, clinical prevention, and treatment of cardiotoxic anticancer drugs.
Furthermore, this book is essential for students, cardiologists, cardio-oncologists, and heart failure researchers.
Table of Contents
Part 1. Epidemiology & Cardiac Signaling.- 1. Risk Factors Associated with Anthracycline Induced Cardiac Dysfunction.- 2. Multilevel Drivers of Disparities in Cardio-oncology.- 3. Cardiotoxicity, Cancer Therapies, and Cardiac Cell Signaling.- 4. Phytochemicals in Cardiotoxicity and Cardioprotection.- Part II. Current Trends in Detection and Management.- 5. Detection, Prevention, & Management of Anthracycline-induced Cardiotoxicity.- 6. Pharmacotherapies in Prevention of Myocardial Oxidative Stress.- 7. Optimizing Cardiovascular Safety: Cardiotoxicity Prevention in Tyrosine Kinase Inhibitor, Monoclonal Antibody, Proteosome Inhibitor, and 5-Fluorouracil Anticancer Therapies.- 8. The Future of Cardio-oncology.
